The new drug could provide relief for around 1,000 women in England, but 1.5 million in the UK suffer with the condition ...

Daily hormone combination pill is approved The National Institute for Health and Care Excellence has recommended relugolix combination therapy—a combination of relugolix, estradiol, and norethisterone ...

Bethany Backhouse was told she would require endometriosis surgery two years ago - but she is yet to be added to the waiting ...

A new pill designed to revolutionise endometriosis treatment has been approved for use on the NHS. The combination drug, relugolix–estradiol–norethisterone (also known as relugolix combination therapy ...

Relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo) is the first long-term daily ...

A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to ...

Discover the newly approved endometriosis pill, Ryeqo, by NHS England, an innovative treatment offering hope to women ...

"For those with a history of previous medical or surgical treatment for their endometriosis, Relugolix CT is an alternative ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Women’s health experts issue warning on limitations of ‘miracle’ endometriosis pill - Debilitating condition affects around 1 ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...